Legal & General Group PLC Brainstorm Cell Therapeutics Inc. Transaction History

Legal & General Group PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$3.01 - $4.01 $11,684 - $15,566	-3,882 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$3.46 - $7.88 $1,245 - $2,836	360 Added 10.22%	3,882 $15,000
Q3 2020 Nov 13, 2020	SELL	$11.19 - $16.92 $9,813 - $14,838	-877 Reduced 19.94%	3,522 $60,000
Q2 2020 Aug 14, 2020	BUY	$4.42 - $12.66 $19,443 - $55,691	4,399 New	4,399 $49,000

10.8M

160K

30.5K

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $81.4M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.